Skip to main content

Closed

LGND: Ligand Pharmaceuticals Incorporated Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

80thpctl

Volume

0.68×avg

Market Cap

5.76BUSD

P/E Ratio

36.7TTM

Div Yield

-ann

Ligand Pharmaceuticals Incorporated

LGNDNASDAQ Global Market·USD·Closed

Ligand Pharmaceuticals Incorporated

LGNDNASDAQ·USD·Closed

$287.54

−2.95%

$287.54

−$8.75 (2.95%)

52W Range

80thpctl

Volume

0.68×avg

Mkt Cap

5.76BUSD

P/E

36.7TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings